Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 gene in child from Russia

Cover Page


Autosomal dominant hypophosphatemic rickets (ADHR) is a rare disorder characterized of renal phosphate wasting and rickets/osteomalacia. ADHR is caused by mutations in a circulating peptide, fibroblast growth factor 23 (FGF23). The clinical manifestations depend on the age of patients and the importance of hypophosphatemia. In childhood, clinical manifestations are rickets with lower extremity deformities. In adult onset, it can cause osteomalacia, osteoporosis, bone pain, tiredness. ADHR displays incomplete penetrance and variability in age of onset of clinical features. Biochemical and hormonal markers of the disease are hypophosphatemia, hyperphosphaturia, increased alkaline phosphatase level and a normal level of 1,25(OH) 2D. We present the first report a baby with ADHR from Russia which one was found heterozygous for the R179Q mutation in FGF23 gene.

About the authors

Kristina S. Kulikova

Endocrinology Research Centre

Author for correspondence.
ORCID iD: 0000-0002-0434-9088
SPIN-code: 4931-5238

Russian Federation, Dm.Ulyanova street, 117036 Moscow, Russia

Eugeny V. Vasiliev

Endocrinology Research Centre

ORCID iD: 0000-0003-1107-362X
SPIN-code: 5767-1569

Russian Federation, Dm.Ulyanova street, 117036 Moscow

Vasily M. Petrov

Endocrinology Research Centre

ORCID iD: 0000-0002-0520-9132
SPIN-code: 4358-2147

Russian Federation, Dm.Ulyanova street, 117036 Moscow

Anatoly N. Tiulpakov

Endocrinology Research Centre

ORCID iD: 0000-0001-8500-4841
SPIN-code: 4358-2147

Russian Federation, Dm.Ulyanova street, 117036 Moscow


  1. White KE, Evans WE, O'Riordan JLH, et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26(3):345-348. doi: 10.1038/81664
  2. Sommer S, Berndt T, Craig T, Kumar R. The phosphatonins and the regulation of phosphate transport and vitamin D metabolism. J Steroid Biochem Mol Biol. 2007;103(3-5):497-503. doi: 10.1016/j.jsbmb.2006.11.010
  3. Kumar R, Folpe AL, Mullan BP. Tumor-Induced Osteomalacia. Transl Endocrinol Metab. 2015;7(3):1871.
  4. Jonsson KB, Zahradnik R, Larsson T, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med. 2003;348(17):1656-1663. doi: 10.1056/NEJMoa020881
  5. White KE, Carn G, Lorenz-Depiereux B, et al. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int. 2001;60(6):2079-2086. doi: 10.1046/j.1523-1755.2001.00064.x
  6. Bai XY, Miao D, Goltzman D, Karaplis AC. The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem. 2003;278(11):9843-9849. doi: 10.1074/jbc.M210490200
  7. Feng JQ, Ward LM, Liu S, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006;38(11):1310-1315. doi: 10.1038/ng1905
  8. Yamamoto T, Imanishi Y, Kinoshita E, et al. The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome. J Bone Miner Metab. 2005;23(3):231-237. doi: 10.1007/s00774-004-0589-9
  9. Lim YH, Ovejero D, Derrick KM, et al. Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy. J Am Acad Dermatol. 2016;75(2):420-427. doi: 10.1016/j.jaad.2015.11.012
  10. Econs MJ, McEnery PT. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab. 1997;82(2):674-681. doi: 10.1210/jcem.82.2.3765
  11. Sun Y, Wang O, Xia W, et al. FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets. J Bone Miner Metab. 2012;30(1):78-84. doi: 10.1007/s00774-011-0285-5
  12. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164. doi: 10.1093/nar/gkq603
  13. Stenson PD, Mort M, Ball EV, et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet. 2017;136(6):665-677. doi: 10.1007/s00439-017-1779-6
  14. Thacher T. Radiographic scoring method for the assessment of the severity of nutritional rickets. J Trop Pediatr. 2000;46(3):132-139. doi: 10.1093/tropej/46.3.132
  15. Bergwitz C, Juppner H. FGF23 and syndromes of abnormal renal phosphate handling. Adv Exp Med Biol. 2012;728:41-64. doi: 10.1007/978-1-4614-0887-1_3
  16. Seton M, Juppner H. Autosomal dominant hypophosphatemic rickets in an 85 year old woman: characterization of her disease from infancy through adulthood. Bone. 2013;52(2):640-643. doi: 10.1016/j.bone.2012.11.012
  17. Negri AL, Negrotti T, Alonso G, Pasqualini T. [Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation in one family]. Medicina (B Aires). 2004;64(2):103-106.
  18. Imel EA, Hui SL, Econs MJ. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res. 2007;22(4):520-526. doi: 10.1359/jbmr.070107
  19. Carpenter TO, Imel EA, Ruppe MD, et al. Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. J Clin Invest. 2014;124(4):1587-1597. doi: 10.1172/JCI72829

Supplementary files

There are no supplementary files to display.



Abstract - 3763

PDF (Russian) - 405



Copyright (c) 2018 Kulikova K., Vasiliev E., Petrov V., Tiulpakov A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies